Pfizer's prostate cancer drug combination gets US FDA priority review - Reuters
Pfizer's prostate cancer drug combination gets US FDA priority review Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPUjI4VHBuUkcxNU9iMkQ4eE5oWmJXblI1S0pRcTZWMWtGY1hqbFhaelVwR0Z4MFFkbHdqTlRULVItTXluWXpMV1hRRmVFd1B2dmNKdDdUZUxNRE15SHp1anJaVVBGdDc0NnV3bS1GaDA5clkzYkM1by1qVi1BdG9hdlJSeV8wUTJxVmpuc2UtTEV3anR2VjZ4bUJ3OVFwUTkyN1l2TVdyYTdmYWJsX1J2MUZPTmVLYzh2R0dHLUZ3?oc=5" target="_blank">Pfizer's prostate cancer drug combination gets US FDA priority review</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMPfizer to cut around 330 jobs in Italy - Reuters
Pfizer to cut around 330 jobs in Italy Reuters
October 7, 2026 at 08:16 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMMexico says FDA lettuce probe did not conclusively identify contamination source - Reuters
Mexico says FDA lettuce probe did not conclusively identify contamination source Reuters
October 3, 2026 at 11:43 PM